News & Events / Events / Webinar
Chemical Exposure Profiling of Alzheimer’s Patients
This webinar presents a comprehensive overview of chemical exposure profiling in Alzheimer’s patients using Panome Bio’s Targeted Exposomics™ and Discovery Exposomics™ platforms. Learn how quantitative exposure biomarkers were identified through Targeted Exposomics and how broad, hypothesis-generating chemical features were uncovered using Discovery Exposomics and its 32,000+ compound database.
The session walks through key findings from Panome’s in-house study, including exposure signatures, chemical classes of interest, and the potential role of environmental chemicals in Alzheimer’s disease biology.
PRESENTED BY:
Ethan Stancliffe, PhD
Dr. Stancliffe is the Senior Director of R&D at Panome Bio. He completed his PhD work in Computational and Systems Biology at Washington University in St. Louis with research focused on computational methods for the analysis and processing of untargeted metabolomics data. Dr. Stancliffe also holds a BS in Biomedical Engineering and Applied Mathematics from the University of Iowa.
Register now
Your privacy is important to us.
We’ll never share your information.